Prions: What Are They Good For?

Annual Review of Cell and Developmental Biology

Volumn 31, Issue , 2015, Pages 149-169

  Si, Kausik ^a  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Amyloids; Functional prions; Prions

Indexed keywords

AMYLOID; PRION PROTEIN; RIBONUCLEOPROTEIN; PRION;

AMINO ACID SEQUENCE; ARTICLE; EPIGENETICS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NERVE CELL PLASTICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOMERIZATION; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; VIRAL CLEARANCE; ANIMAL; METABOLISM; PROTEINOSIS;

AMYLOID; ANIMALS; HUMANS; PRIONS; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN CONFORMATION;

EID: 84947276177     PISSN: 10810706     EISSN: 15308995     Source Type: Book Series    
DOI: 10.1146/annurev-cellbio-100913-013409     Document Type: Article

References (114)

1. Adams DH. 1970. The nature of the scrapie agent. A review of recent progress. Pathol. Biol. 18:559-77
2. Aguzzi A, Weissmann C. 1998. Prion diseases. Haemophilia 4:619-27
3. Alberti S, Halfmann R, King O, Kapila A, Lindquist S. 2009. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137:146-58
4. Ashe KH, Zahs KR. 2010. Probing the biology of Alzheimer's disease in mice. Neuron 66:631-45
5. Bailey CH, Kandel ER, Si K. 2004. The persistence of long-term memory: a molecular approach to selfsustaining changes in learning-induced synaptic growth. Neuron 44:49-57
6. Bernhardt HS. 2012. The RNA world hypothesis: the worst theory of the early evolution of life (except for all the others)a. Biol. Direct 7:23
7. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. 2004. Molecular pathways to neurodegeneration. Nat. Med. 10(Suppl.):S2-9
8. Brangwynne CP, Eckmann CR, Courson DS, Rybarska A, Hoege C, et al. 2009. Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science 324:1729-32
9. Cai X, Chen J, Xu H, Liu S, Jiang QX, et al. 2014. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156:1207-22
10. Cai X, Chen ZJ. 2014. Prion-like polymerization as a signaling mechanism. Trends Immunol. 35:622-30
11. Caudron F, Barral Y. 2013. A super-assembly of Whi3 encodes memory of deceptive encounters by single cells during yeast courtship. Cell 155:1244-57
12. Cech TR. 2009. Evolution of biological catalysis: ribozyme to RNP enzyme. Cold Spring Harb. Symp. Quant. Biol. 74:11-16
13. Chernoff YO. 2004. Amyloidogenic domains, prions and structural inheritance: rudiments of early life or recent acquisition? Curr. Opin. Chem. Biol. 8:665-71
14. Chien P,Weissman JS. 2001. Conformational diversity in a yeast prion dictates its seeding specificity. Nature 410:223-27
15. Chien P, Weissman JS, DePace AH. 2004. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 73:617-56
16. Collinge J, Clarke AR. 2007. A general model of prion strains and their pathogenicity. Science 318:930-36
17. Coustou V,Deleu C, Saupe S, Begueret J. 1997. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. PNAS 94:9773-78
18. Crick F. 1984. Memory and molecular turnover. Nature 312:101
19. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. 2010. Prion-like disorders: blurring the divide between transmissibility and infectivity. J. Cell Sci. 123:1191-201
20. Darwin C. 2003 (1859). The Origin of Species. New York: Signet
21. Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, Liebman SW. 2004. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. PNAS 101:12934-39
22. Dobson CM. 2004. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 15:3-16
23. Du Z, Park KW, Yu H, Fan Q, Li L. 2008. Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. Nat. Genet. 40:460-65
24. Dudai Y. 2002. Molecular bases of long-term memories: a question of persistence. Curr. Opin. Neurobiol. 12:211-16
25. Eaglestone SS, Cox BS, TuiteMF. 1999. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J. 18:1974-81
26. Eisenberg D, Jucker M. 2012. The amyloid state of proteins in human diseases. Cell 148:1188-203
27. Encalada SE, Goldstein LS. 2014. Biophysical challenges to axonal transport: motor-cargo deficiencies and neurodegeneration. Annu. Rev. Biophys. 43:141-69
28. Fioriti L, Myers C, Huang YY, Li X, Stephan JS, et al. 2015. The persistence of hippocampal-based memory requires protein synthesis mediated by the prion-like protein CPEB3. Neuron 86(6):1433-48
29. Fowler DM, Koulov AV, Alory-Jost C,Marks MS, Balch WE, Kelly JW. 2006. Functional amyloid formation within mammalian tissue. PLOS Biol. 4:e6
30. Franklin TB, Russig H, Weiss IC, Graff J, Linder N, et al. 2010. Epigenetic transmission of the impact of early stress across generations. Biol. Psychiatry 68:408-15
31. Giasson BI, Forman MS,Higuchi M, Golbe LI, Graves CL, et al. 2003. Initiation and synergistic fibrillization of and α-synuclein. Science 300:636-40
32. Griffith JS. 1967. Self-replication and scrapie. Nature 215:1043-44
33. Halfmann R, Jarosz DF, Jones SK, Chang A, Lancaster AK, Lindquist S. 2012. Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature 482:363-68
34. Han TW, Kato M, Xie S,Wu LC, Mirzaei H, et al. 2012. Cell-free formation of RNA granules: bound RNAs identify features and components of cellular assemblies. Cell 149:768-79
35. Harbi D, Harrison PM. 2014. Classifying prion and prion-like phenomena. Prion 8:161-65
36. Hartl FU, Bracher A, Hayer-HartlM. 2011. Molecular chaperones in protein folding and proteostasis. Nature 475:324-32
37. Heinrich SU, Lindquist S. 2011. Protein-only mechanism induces self-perpetuating changes in the activity of neuronal Aplysia cytoplasmic polyadenylation element binding protein (CPEB). PNAS 108:2999-3004
38. Herb BR, Wolschin F, Hansen KD, Aryee MJ, Langmead B, et al. 2012. Reversible switching between epigenetic states in honeybee behavioral subcastes. Nat. Neurosci. 15:1371-73
39. Holmes BB, Diamond MI. 2014. Prion-like properties of protein: the importance of extracellular as a therapeutic target. J. Biol. Chem. 289:19855-61
40. Holmes DL, Lancaster AK, Lindquist S, Halfmann R. 2013. Heritable remodeling of yeast multicellularity by an environmentally responsive prion. Cell 153:153-65
41. Horwich AL, Weissman JS. 1997. Deadly conformations-protein misfolding in prion disease. Cell 89:499-510
42. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448-61
43. Ishimaru D, Andrade LR, Teixeira LS, Quesado PA, Maiolino LM, et al. 2003. Fibrillar aggregates of the tumor suppressor p53 core domain. Biochemistry 42:9022-27
44. Iwasaki M, Paszkowski J. 2014. Epigenetic memory in plants. EMBO J. 33:1987-98
45. Jarosz DF, Brown JC,Walker GA, Datta MS, Ung WL, et al. 2014. Cross-kingdom chemical communication drives a heritable, mutually beneficial prion-based transformation of metabolism. Cell 158:1083-93
46. Johnson AP, Cleaves HJ, Dworkin JP, Glavin DP, Lazcano A, Bada JL. 2008. The Miller volcanic spark discharge experiment. Science 322:404
47. Kato M, Han TW, Xie S, Shi K, Du X, et al. 2012. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell 149:753-67
48. Keene JD, Tenenbaum SA. 2002. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell 9:1161-67
49. Keleman K, Kruttner S, Alenius M, Dickson BJ. 2007. Function of the Drosophila CPEB protein Orb2 in long-term courtship memory. Nat. Neurosci. 10:1587-93
50. Kelly JW. 1998. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8:101-6
51. King OD, Gitler AD, Shorter J. 2012. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 1462:61-80
52. Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, et al. 2004. Fibrillization of α-synuclein and in familial Parkinson's disease caused by the A53T α-synuclein mutation. Exp. Neurol. 187:279-88
53. Kruttner S, Stepien B, Noordermeer JN, Mommaas MA, Mechtler K, et al. 2012. Drosophila CPEB Orb2A mediates memory independent of its RNA-binding domain. Neuron 76:383-95
54. Kwon I, Kato M, Xiang S,Wu L, Theodoropoulos P, et al. 2013. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell 155:1049-60
55. Lansbury PT Jr. 1997. Structural neurology: Are seeds at the root of neuronal degeneration? Neuron 19:1151-54
56. Lee C, Zhang H, Baker AE, Occhipinti P, Borsuk ME, Gladfelter AS. 2013. Protein aggregation behavior regulates cyclin transcript localization and cell-cycle control. Dev. Cell 25:572-84
57. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, et al. 2004. Synthetic mammalian prions. Science 305:673-76
58. Liberski PP. 2012. Historical overview of prion diseases: a view from afar. Folia Neuropathol. 50:1-12
59. Liebman SW, Chernoff YO. 2012. Prions in yeast. Genetics 191:1041-72
60. Lim JP, Brunet A. 2013. Bridging the transgenerational gap with epigeneticmemory. Trends Genet. 29:176-86
61. Lisman J. 1994. The CaM kinase II hypothesis for the storage of synaptic memory. Trends Neurosci. 17:406-12
62. Lynch G, Baudry M. 1984. The biochemistry of memory: a new and specific hypothesis. Science 224:1057-63
63. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, et al. 2009. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325:328-32
64. Majumdar A, Cesario WC, White-Grindley E, Jiang H, Ren F, et al. 2012. Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of memory. Cell 148:515-29
65. Malinovska L, Kroschwald S, Alberti S. 2013. Protein disorder, prion propensities, and self-organizingmacromolecular collectives. Biochim. Biophys. Acta 1834:918-31
66. Martin KC, Barad M, Kandel ER. 2000. Local protein synthesis and its role in synapse-specific plasticity. Curr. Opin. Neurobiol. 10:587-92
67. Miller SL, Urey HC. 1959. Organic compound synthesis on the primitive earth. Science 130:245-51
68. Newby GA, Lindquist S. 2013. Blessings in disguise: biological benefits of prion-like mechanisms. Trends Cell Biol. 23:251-59
69. Patel BK, Gavin-Smyth J, Liebman SW. 2009. The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat. Cell Biol. 11:344-49
70. Pavlopoulos E, Trifilieff P, Chevaleyre V, Fioriti L, Zairis S, et al. 2011. Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic plasticity and memory storage. Cell 147:1369-83
71. Petrovska I,Nuske E, MunderMC,Kulasegaran G, MalinovskaL, et al. 2014. Filament formation by metabolic enzymes is a specific adaptation to an advanced state of cellular starvation. eLife 3:e02409
72. Polymenidou M, Cleveland DW. 2012. Prion-like spread of protein aggregates in neurodegeneration. J. Exp. Med. 209:889-93
73. Prusiner SB. 1991. Molecular biology of prion diseases. Science 252:1515-22
74. Prusiner SB. 1998. Prions. PNAS 95:13363-83
75. Prusiner SB. 2013. Biology and genetics of prions causing neurodegeneration. Annu. Rev. Genet. 47:601-23
76. Prusiner SB,McKinleyMP, Bowman KA, Bolton DC, Bendheim PE, et al. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-58
77. Ramanan VK, Saykin AJ. 2013. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am. J. Neurodegenerat. Dis. 2:145-75
78. RamaswamiM,Taylor JP, Parker R. 2013. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 154:727-36
79. Raveendra BL, Siemer AB, Puthanveettil SV, Hendrickson WA, Kandel ER, McDermott AE. 2013. Characterization of prion-like conformational changes of the neuronal isoform of Aplysia CPEB. Nat. Struct. Mol. Biol. 20:495-501
80. Reik W. 2007. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447:425-32
81. Richter JD. 2007. CPEB: a life in translation. Trends Biochem. Sci. 32:279-85
82. Richter JD, KlannE. 2009. Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev. 23:1-11
83. Ringrose L, Paro R. 2007. Polycomb/Trithorax response elements and epigenetic memory of cell identity. Development 134:223-32
84. Ripaud L, Chumakova V, Antonin M, Hastie AR, Pinkert S, et al. 2014. Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome. PNAS 111:18219-24
85. Roberts RB, Flexner LB. 1969. The biochemical basis of long-term memory. Q. Rev. Biophys. 2:135-73
86. Robertson MP, Joyce GF. 2012. The origins of the RNA world. Cold Spring Harb. Perspect. Biol. 4:006742
87. Rogoza T, Goginashvili A, Rodionova S, Ivanov M, Viktorovskaya O, et al. 2010. Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1. PNAS 107:10573-77
88. Roth DM, Balch WE. 2011. Modeling general proteostasis: proteome balance in health and disease. Curr. Opin. Cell Biol. 23:126-34
89. SargeKD, Park-Sarge OK. 2009. Mitotic bookmarking of formerly active genes: keeping epigeneticmemories from fading. Cell Cycle 8:818-23
90. Seong KH, Li D, Shimizu H, Nakamura R, Ishii S. 2011. Inheritance of stress-induced, ATF-2-dependent epigenetic change. Cell 145:1049-61
91. Shorter J, Lindquist S. 2005. Prions as adaptive conduits of memory and inheritance. Nat. Rev. Genet. 6:435-50
92. Si K, Choi YB,White-GrindleyE,MajumdarA,KandelER. 2010. AplysiaCPEBcan form prion-likemultimers in sensory neurons that contribute to long-term facilitation. Cell 140:421-35
93. Si K, Giustetto M, Etkin A, Hsu R, Janisiewicz AM, et al. 2003a. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia. Cell 115:893-904
94. Si K, Lindquist S, Kandel ER. 2003b. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 115:879-91
95. Skovronsky DM, Lee VM, Trojanowski JQ. 2006. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1:151-70
96. Soto C. 2012. Transmissible proteins: expanding the prion heresy. Cell 149:968-77
97. Stephan JS, Fioriti L, Lamba N, Colnaghi L, Karl K, et al. 2015. The CPEB3 protein is a functional prion that interacts with the actin cytoskeleton. Cell Rep. 11(11):1772-85
98. Steward O, Schuman EM. 2001. Protein synthesis at synaptic sites on dendrites. Annu. Rev. Neurosci. 24:299-325
99. Suzuki G, Shimazu N, Tanaka M. 2012. A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science 336:355-59
100. Tariq M, Wegrzyn R, Anwar S, Bukau B, Paro R. 2013. Drosophila GAGA factor polyglutamine domains exhibit prion-like behavior. BMC Genomics 14:374
101. Tompa P, Friedrich P. 1998. Prion proteins as memory molecules: a hypothesis. Neuroscience 86:1037-43
102. True HL, Berlin I, Lindquist SL. 2004. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature 431:184-87
103. True HL, Lindquist SL. 2000. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 407:477-83
104. Walsh DM, Selkoe DJ. 2004. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44:181-93
105. Wang L, Maji SK, Sawaya MR, Eisenberg D, Riek R. 2008. Bacterial inclusion bodies contain amyloid-like structure. PLOS Biol. 6:e195
106. White-Grindley E, Li L, Mohammad Khan R, Ren F, Saraf A, et al. 2014. Contribution of Orb2A stability in regulated amyloid-like oligomerization of Drosophila Orb2. PLOS Biol. 12:e1001786
107. Wickner RB. 1994. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264:566-69
108. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T. 2007. Prions of fungi: inherited structures and biological roles. Nat. Rev. Microbiol. 5:611-18
109. Wickner RB, Masison DC, Edskes HK. 1995. [PSI] and [URE3] as yeast prions. Yeast 11:1671-85
110. Wickner RB, Taylor KL, Edskes HK, Maddelein ML. 2000. Prions: portable prion domains. Curr. Biol. 10:R335-37
111. Wiltzius JJ, Landau M, Nelson R, Sawaya MR, Apostol MI, et al. 2009. Molecular mechanisms for proteinencoded inheritance. Nat. Struct. Mol. Biol. 16:973-78
112. Xu H, He X, Zheng H, Huang LJ, Hou F, et al. 2014. Structural basis for the prion-like MAVS filaments in antiviral innate immunity. eLife 3:e01489
113. Zaidi SK, YoungDW, MontecinoM,Lian JB, Stein JL, et al. 2010. Architectural epigenetics:mitotic retention of mammalian transcriptional regulatory information. Mol. Cell. Biol. 30:4758-66
114. Zeybel M, Hardy T,Wong YK, Mathers JC, Fox CR, et al. 2012. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat. Med. 18:1369-77